Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Eli Lilly's 340B data policy draws new opposition from Missouri AG, Massachusetts hospitals

A controversial requirement for 340B hospitals to submit claims-level data to earn statutory drug discounts has earned a cease-and-desist letter from Missouri's attorney general and yet another lawsuit from disgruntled hospitals.

We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.

Read the original at fiercehealthcare.com →

More in Health & Medicine

More from Wednesday 28 October →